Neonatal Hypoglycemia: Recognition, Risk Factors, and Management

Neonatal hypoglycemia is the most common metabolic problem in newborns and a key topic for nursing exams. Because glucose is the primary fuel for the newborn brain, early recognition and prompt treatment are essential to prevent permanent neurologic injury.

Definition

• Neonatal hypoglycemia is a blood glucose level below 40–45 mg/dL in the first 48 hours of life.
• It is the most common metabolic problem in newborns.
• Prolonged or severe hypoglycemia can cause brain injury and developmental delay.

Risk Factors

Maternal factors

• Diabetes (gestational or pregestational)
• Obesity
• Toxemia
• Beta-blocker use

Infant factors

• Prematurity
• Small for gestational age (SGA)
• Large for gestational age (LGA)
• Intrauterine growth restriction (IUGR)

Perinatal factors

• Birth asphyxia
• Cold stress
• Sepsis
• Polycythemia
• Delayed feeding

Why these matter

• Infants of diabetic mothers (IDMs) are at highest risk. Maternal hyperglycemia causes fetal hyperinsulinemia, and excess insulin continues after birth.
• Premature and SGA infants have limited glycogen stores and immature gluconeogenesis.
• Birth asphyxia depletes glycogen stores; cold stress and sepsis increase glucose utilization.

Signs and Symptoms

• Jitteriness is the most common sign; tremors stop when the limb is held.
• Seizures may be subtle — eye deviation, bicycling movements, apnea.
• Early signs: hypothermia and poor feeding (precede neurologic symptoms).
• Neurologic signs: lethargy, hypotonia, high-pitched cry, poor feeding.
• Autonomic signs: sweating, tachycardia, hypothermia, pallor.
• Respiratory signs: apnea, tachypnea, grunting, cyanosis.

Prevention and Treatment

• Early feeding is the most important preventive measure — initiate within the first hour of life.
• Asymptomatic hypoglycemia → feeding first, then recheck in 30–60 minutes.
• Symptomatic hypoglycemia → immediate IV 10% dextrose (never 25% in newborns).
• Persistent hypoglycemia → investigate for hyperinsulinism or adrenal insufficiency.
• Wean IV dextrose gradually to prevent rebound hypoglycemia.

Complications

• Neuroglycopenia is the most serious complication — the brain is deprived of glucose, causing neuronal injury.
• Long-term outcomes: cognitive impairment, developmental delay, motor deficits.
• Seizures and apnea increase the risk of brain injury.
• Early detection and treatment prevent complications.

High-Yield Exam Traps

• Do not delay feeding in at-risk newborns.
• Do not ignore jitteriness — it is the most common sign.
• Do not treat asymptomatic hypoglycemia with IV dextrose alone; feeding is first-line.
• Do not use 25% dextrose in newborns — use 10% dextrose.
• Do not stop IV dextrose abruptly; wean slowly to prevent rebound hypoglycemia.
• Do not wait for lab confirmation in symptomatic infants — treat immediately.
• Do not forget that infants of diabetic mothers are at highest risk.
• Do not assume hypoglycemia is benign — it can cause permanent brain injury.

Key takeaways

• Neonatal hypoglycemia = blood glucose <40–45 mg/dL in the first 48 hours.
• Infants of diabetic mothers, SGA, LGA, and preterm infants are at highest risk.
• Jitteriness is the most common sign; seizures and apnea are red flags.
• Asymptomatic: feed and recheck. Symptomatic or <25 mg/dL: IV 10% dextrose bolus, then infusion.
• Never use 25% dextrose in newborns; always wean IV dextrose gradually.
• Early feeding within the first hour of life is the best prevention.